Learn More
Invitrogen™ VEGF-D (FIGF) Human ELISA Kit
Sandwich ELISA Kit
626.00€ - 4715.00€
Especificaciones
Número de acceso | O43915 |
---|---|
Sensibilidad del ensayo | 0,2 ng |
ensayo | ELISA sandwich de fase sólida |
Conjugado | Biotina |
Tipo de producto | Kit de ELISA |
Código de producto | Marca | Cantidad | Precio | Cantidad y disponibilidad | |||||
---|---|---|---|---|---|---|---|---|---|
Código de producto | Marca | Cantidad | Precio | Cantidad y disponibilidad | |||||
15474993
|
Invitrogen™
EHFIGF |
96 pruebas |
626.00€
1 set |
Fecha estimada de envío: 17-05-2024
Inicie sesión para ver el stock |
|||||
17864200
|
Invitrogen™
EHFIGFX10 |
10 × 96 pruebas |
4715.00€
paquete de 10 |
Fecha estimada de envío: 27-05-2024
Inicie sesión para ver el stock |
|||||
17115449
|
Invitrogen™
EHFIGFX5 |
5 × 96 pruebas |
2635.00€
cada uno |
Fecha estimada de envío: 24-05-2024
Inicie sesión para ver el stock |
|||||
Descripción
The Human Vascular Endothelial Growth Factor D (Hu VEGFD/FIGF) ELISA quantitates Hu VEGFD in human serum, plasma, or cell culture medium. The assay will exclusively recognize both natural and recombinant Hu VEGFD. Principle of the method The Human VEGFD solid-phase sandwich ELISA (enzyme-linked immunosorbent assay) is designed to measure the amount of the target bound between a matched antibody pair. A target-specific antibody has been pre-coated in the wells of the supplied microplate. Samples, standards, or controls are then added into these wells and bind to the immobilized (capture) antibody. The sandwich is formed by the addition of the second (detector) antibody, a substrate solution is added that reacts with the enzyme-antibody-target complex to produce measurable signal. The intensity of this signal is directly proportional to the concentration of target present in the original specimen. Rigorous validation Each manufactured lot of this ELISA kit is quality tested for criteria such as sensitivity, specificity, precision, and lot-to-lot consistency. See manual for more information on validation.
Several forms of VEGF have been identified, including VEGF, VEGF-B, VEGF-C and VEGF-D (also designated FIGF). Characteristic of VEGF proteins, the central region of VEGF-D contains eight cysteine residues. These residues are essential for homodimerization. VEGFD may play a role in tumor progression, as it is induced by c-Fos, which is required for conversion of early stage tumors to malignant tumors. It has been observed that overexpression of VEGF-D induces morphological changes in fibroblasts.Especificaciones
O43915 | |
ELISA sandwich de fase sólida | |
Kit de ELISA | |
Plasma, Sobrenadante, Suero | |
Humano | |
Lector de microplacas colorimétrico | |
FIGF,VEGF-D. | |
< 10 % | |
RUO | |
De 2 °C a 8 °C | |
Humano | |
4 h 45 min |
0,2 ng | |
Biotina | |
Quimiocinas y receptores | |
Este kit de ELISA no muestra reactividad cruzada con las siguientes citoquinas probadas: angiogenina humana, BDNF, BLC, CNTF, ENA-78, FGF-4, IL-1 alfa, IL-1 beta, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-11, IL-12 p70, IL-12 p40, IL-13, IL-15, IL-309, IP-10, FGF-4, FGF-6, FGF-7, G-CSF, GDNF, GM-CSF, IFN-gamma, IGFBP-2, IGFBP-3, IGFBP-4, leptina (OB), MCP-1, MCP-2, MCP-3, MDC, MIF, MIG, MIP-1 alfa, MIP-1 beta, MIP-1 delta, PARC, PDGF, RANTES, SCF, SDF-1 alfa, TARC, TGF-beta, TIMP-1, TIMP-2, TNF-alfa, TNF-beta, TPO, VEGF-A. | |
ELISA, ensayos de proteínas, biología de proteínas, biología del cáncer, inmunología, neurociencia, neurología, detección de proteínas, análisis de proteínas | |
2277 | |
< 12 % | |
Peroxidasa de rábano picante (HRP) | |
Inmunología | |
VEGF-D, VEGFD | |
1 h 20 min |